Table 1.
Selection of JAK inhibitors currently in development for treatment of MPN
Selection of JAK inhibitors currently in development for treatment of MPN

*Ongoing: for current information please refer to http://clinicaltrials.gov.

†On hold: development of fedratinib currently on hold secondary to cases of Werneckie's encephalophathy.

or Create an Account

Close Modal
Close Modal